57 new patents were registered in 2012. Galderma is the leader in filing patents in dermatology 57 new patents were registered in 2012. Galderma is the leader in filing patents in dermatology

Key Facts

Galderma is one of the world's leading investors in dermatology research and development.

  • 11,000 molecules screened since 1981
  • 1,750 pharmaceutical registrations in all Galderma's areas of expertise
  • 12 new chemical entities are in development and & products are currently tested in phase II and phase III clinical studies
  • 6,500 patent applications and patents have been filed since 1981
  • 1,700 scientific publications in 2012
  • 20 projects in early and full development

© 2013-2016 Galderma Laboratories, L.P. United States, All trademarks are the property of their respective owners. All Rights Reserved. This site intended for U.S. audiences only.

Custom Photography by: © Stewart Cohen Pictures and TOM HUSSEY Photography, LLC

Corporate site | Privacy | Legal | Compliance Program | Site Map